Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDC*lung01 in NSCLC
NCT03970746Phase 2Active, not recruiting
- Sponsor
- PDC*line Pharma
- Start
- Sep 2019
- Primary completion
- Jul 2024
- Modality
- Vaccines & Immunotherapeutics, Dendritic Cell Vaccines
- Countries
- 5
01
Overview
A Phase 2 trial of PDC*lung01 in non-small cell lung cancer (NSCLC), sponsored by PDC*line Pharma. Started Sep 2019; status: active, not recruiting.
02
Drugs
PDC*lung01
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03970746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970746.